Study analysis · The lancet. Diabetes & endocrinology · 2024
Vitamin D supplements don't prevent colds after all—despite what you've heard.
Taking vitamin D pills doesn't really stop most people from getting colds or breathing infections.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study combines results from many smaller experiments where vitamin D was tested against fake pills. It shows that overall, vitamin D doesn't clearly prevent colds and flu, but it might help some people like kids or those taking daily small doses.
What’s the bottom line?
Scientists looked at many studies to see if taking vitamin D stops people from getting colds.
How strong is this study?
This was a very thorough study that looked at lots of experiments done properly, but some were missing information and there might be some experiments we don't know about. This means we can mostly trust the results, but not completely.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 545 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Overall effect not statistically significant (CI includes 1.00), but some subgroups showed significant effects
Key takeaways
- 01
Taking vitamin D did not stop colds overall.
- 02
In some groups like kids, it might help a little, but it's not certain.
- 03
For most people, vitamin D doesn't prevent colds, but it's safe to take.
Surprising findings
- Vitamin D didn't reduce overall infection risk despite previous research suggesting it might.Many health influencers and some studies have promoted vitamin D for immunity, making this null result counter to popular belief.
- Publication bias may have made vitamin D seem more effective than it is.It suggests missing studies could have skewed past meta-analyses, overstating benefits.
Practical takeaways
If you take vitamin D for cold prevention, focus on daily low-to-moderate doses (400–1000 IU) rather than high or infrequent doses.
Effects are not robustly proven, and benefits may be limited to specific groups like children.
medium confidenceDon't rely solely on vitamin D for infection prevention—prioritize proven methods like handwashing and vaccines.
Vitamin D is safe but not a magic bullet for immunity.
high confidenceWhy this study matters
Kids Might Benefit
Vitamin D showed a 26% reduction in respiratory infections for children aged 1–15 (OR 0.74), but this wasn't confirmed by deeper analysis and could be due to chance.
Parents often give kids supplements hoping to boost immunity, so this hints at a possible benefit for younger ages.
Daily Dosing Works Better
Daily vitamin D supplementation reduced ARI risk by 16% (OR 0.84) in 21 trials, but weekly or monthly dosing didn't show consistent benefits.
Many people take supplements sporadically, but this suggests consistency might matter for any potential effect.
Low Doses Beat High Doses
Doses of 400–1000 IU per day reduced infection risk by 30% (OR 0.70), but higher doses showed no benefit, indicating more isn't always better.
People often think mega-doses are more effective, but this study suggests moderation could be key.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at many studies to see if taking vitamin D stops people from getting colds.
Research results
Taking vitamin D did not stop colds overall. In some groups like kids, it might help a little, but it's not certain.
What this means - more context
For most people, vitamin D doesn't prevent colds, but it's safe to take.
Updated systematic review and meta-analysis examining the effect of vitamin D supplementation on preventing acute respiratory infections (ARIs) using data from randomized controlled trials.
Vitamin D supplementation does not significantly reduce overall ARI risk (OR 0.94, 95% CI 0.88–1.00) across 40 trials with 61,589 participants. Subgroup analyses by age, baseline vitamin D status, or dosing regimen showed no consistent protective effects, and the intervention did not affect serious adverse events (OR 0.96, 95% CI 0.90–1.04).
Methods Used
Meta-analysis of 40 double-blind RCTs with placebo or low-dose control, using aggregate data stratified by baseline vitamin D levels and age. Included 61,589 participants from trials approved by ethics committees.
Main Finding
No significant overall reduction in ARI risk with vitamin D supplementation (OR 0.94, 95% CI 0.88–1.00). Subgroup analyses for children, daily dosing, or specific doses showed some reductions but were not robustly supported.
Confidence Level
High reliability due to systematic review of RCTs, pre-registration, and comprehensive analysis, but potential publication bias noted.
Study Flags
Red Flags
- •Potential publication bias
- •Subgroup findings not robust
- •Corrections/errata published
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Vitamin D didn't reduce overall infection risk despite previous research suggesting it might.
Many health influencers and some studies have promoted vitamin D for immunity, making this null result counter to popular belief.
Practical Takeaways
If you take vitamin D for cold prevention, focus on daily low-to-moderate doses (400–1000 IU) rather than high or infrequent doses.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 545 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Systematic Review with Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This study combines results from many smaller experiments where vitamin D was tested against fake pills. It shows that overall, vitamin D doesn't clearly prevent colds and flu, but it might help some people like kids or those taking daily small doses.
Strengths
- Systematic review of RCTs (highest evidence level)
- Large sample size (61,589 participants)
- Pre-specified protocol and subgroup analyses
Weaknesses
- Publication bias suggested by funnel plot asymmetry
- Some trials had unclear risk of bias
- Aggregate data rather than individual participant data
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at many studies to see if taking vitamin D stops people from getting colds.
Research results
Taking vitamin D did not stop colds overall. In some groups like kids, it might help a little, but it's not certain.
What this means - more context
For most people, vitamin D doesn't prevent colds, but it's safe to take.
Updated systematic review and meta-analysis examining the effect of vitamin D supplementation on preventing acute respiratory infections (ARIs) using data from randomized controlled trials.
Vitamin D supplementation does not significantly reduce overall ARI risk (OR 0.94, 95% CI 0.88–1.00) across 40 trials with 61,589 participants. Subgroup analyses by age, baseline vitamin D status, or dosing regimen showed no consistent protective effects, and the intervention did not affect serious adverse events (OR 0.96, 95% CI 0.90–1.04).
Methods Used
Meta-analysis of 40 double-blind RCTs with placebo or low-dose control, using aggregate data stratified by baseline vitamin D levels and age. Included 61,589 participants from trials approved by ethics committees.
Main Finding
No significant overall reduction in ARI risk with vitamin D supplementation (OR 0.94, 95% CI 0.88–1.00). Subgroup analyses for children, daily dosing, or specific doses showed some reductions but were not robustly supported.
Confidence Level
High reliability due to systematic review of RCTs, pre-registration, and comprehensive analysis, but potential publication bias noted.
Study Flags
Red Flags
- •Potential publication bias
- •Subgroup findings not robust
- •Corrections/errata published
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Vitamin D didn't reduce overall infection risk despite previous research suggesting it might.
Many health influencers and some studies have promoted vitamin D for immunity, making this null result counter to popular belief.
Practical Takeaways
If you take vitamin D for cold prevention, focus on daily low-to-moderate doses (400–1000 IU) rather than high or infrequent doses.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 545 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Systematic Review with Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This study combines results from many smaller experiments where vitamin D was tested against fake pills. It shows that overall, vitamin D doesn't clearly prevent colds and flu, but it might help some people like kids or those taking daily small doses.
Strengths
- Systematic review of RCTs (highest evidence level)
- Large sample size (61,589 participants)
- Pre-specified protocol and subgroup analyses
Weaknesses
- Publication bias suggested by funnel plot asymmetry
- Some trials had unclear risk of bias
- Aggregate data rather than individual participant data
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This was a very thorough study that looked at lots of experiments done properly, but some were missing information and there might be some experiments we don't know about. This means we can mostly trust the results, but not completely.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 545 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Overall effect not statistically significant (CI includes 1.00), but some subgroups showed significant effects
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Conflicting evidence
Evidence points in both directions — no clear conclusion yet.
Evidence
Authored by
45 researchersIf this is your work, this is how we attribute it on Fit Body Science. David A. Jolliffe is listed as the lead author.